Cargando…
Understanding Drug Sensitivity and Tackling Resistance in Cancer
Decades of research into the molecular mechanisms of cancer and the development of novel therapeutics have yielded a number of remarkable successes. However, our ability to broadly assign effective, rationally targeted therapies in a personalized manner remains elusive for many patients, and drug re...
Autores principales: | Tyner, Jeffrey W., Haderk, Franziska, Kumaraswamy, Anbarasu, Baughn, Linda B., Van Ness, Brian, Liu, Song, Marathe, Himangi, Alumkal, Joshi J., Bivona, Trever G., Chan, Keith Syson, Druker, Brian J., Hutson, Alan D., Nelson, Peter S., Sawyers, Charles L., Willey, Christopher D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018544/ https://www.ncbi.nlm.nih.gov/pubmed/35195258 http://dx.doi.org/10.1158/0008-5472.CAN-21-3695 |
Ejemplares similares
-
Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer
por: Wu, Wei, et al.
Publicado: (2017) -
EGFR targeted therapy resistance: current status, challenges, and future outlook
por: Bivona, Trever G.
Publicado: (2020) -
Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients
por: Lin, Luping, et al.
Publicado: (2012) -
Adaptive stress signaling in targeted therapy resistance in cancer
por: Pazarentzos, Evangelos, et al.
Publicado: (2015) -
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
por: Neel, Dana S., et al.
Publicado: (2017)